SYNACT · SynAct Pharma AB
Market Cap
968.77M SEK
Shares
56.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close17.1200 SEK
Open17.5000 SEK
Day17.0800–17.7200 SEK
52W close10.6600–24.9500 SEK
Avg vol 30d175K
Last earningsFeb 18, 2027
DataJan 2020–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 10.6600 SEK
Now 17.1200 SEK · 45%
Range high 24.9500 SEK
vs 200-day avg -7%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XSTO:SYNACT | -3.2% | -11.1% | -2.3% | -2.2% | -24.3% |
Exchange listing
- Market
- XSTO
- Ticker
- SYNACT
- ISIN
- SE0008241491
- Security
- —
- Trading currency
- SEK
Company
- Website
- https://synactpharma.com/
- Investor relations
- https://synactpharma.com/en/investors/
Other listings of this company
No other verified listings are available.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2026-10-07 00:00 UTC | Bio Japan, Yokohama, Japan | Event |
| 2026-11-03 00:00 UTC | Interim Report Q3 2026 | Results publication |
| 2026-11-06 00:00 UTC | ACR Convergence 2026, Orlando, FL, USA | Event |
| 2026-11-09 00:00 UTC | BIO Europe, Cologne, Germany | Event |
| 2027-02-18 00:00 UTC | Year-End Report 2026 | Results publication |
Earnings calls
-
Earnings call · Q4 2026 2027-02-18 ScheduledYear-End Report 2026
-
Earnings call · Q3 2026 2026-11-03 ScheduledInterim Report Q3 2026